Keyphrases
Heart Failure with Preserved Ejection Fraction (HFpEF)
100%
Hypokalemia
100%
Serum Potassium
100%
PARAGON-HF
100%
Hyperkalemia
71%
Cardiovascular Mortality
42%
Potassium
42%
Hypo
42%
Preserved Ejection Fraction
42%
High Risk
28%
Heart Failure Hospitalization
28%
Valsartan
28%
Patients with Heart Failure
28%
Sacubitril-valsartan
28%
Confidence Interval
28%
Normokalaemia
28%
Diabetes
14%
Heart Failure
14%
AIMS™
14%
All-cause Mortality
14%
Cause of Death
14%
Renal Impairment
14%
Hazard Ratio
14%
Non-cardiovascular
14%
Non-cardiovascular Mortality
14%
Composite Outcome
14%
Splines
14%
Mineralocorticoid Receptor Antagonists
14%
Ischaemic Aetiology
14%
Impaired Kidney Function
14%
Antagonist Treatment
14%
Clinical Outcomes
14%
Adjusted Hazard Ratio
14%
Medicine and Dentistry
Heart Failure with Preserved Ejection Fraction
100%
Post-Hoc Analysis
100%
Hypokalemia
100%
Cardiovascular System
85%
Congestive Heart Failure
71%
Hyperkalemia
71%
Valsartan
57%
Ejection Fraction
42%
Hazard Ratio
28%
Sacubitril
28%
Diabetes
14%
Kidney Function
14%
Mineralocorticoid Antagonist
14%
Primary Outcome
14%
Pharmacology, Toxicology and Pharmaceutical Science
Heart Failure with Preserved Ejection Fraction
100%
Isotopes of Potassium
100%
Hypokalemia
77%
Hyperkalemia
55%
Congestive Heart Failure
55%
Valsartan/Sacubitril
22%
Valsartan
22%
Mineralocorticoid Antagonist
11%